Diagnostic challenges of today's lung cancer pathology: personalizing therapy by immunohistochemical and molecular biomarkers
Abstract
How to screen for molecular and immunotherapy targets in non-small cell lung cancer.
Lung cancerAdenocarcinomaPersonalized medicineArtificial intelligenceMolecular diagnosticsImmunotherapyTyrosine kinase inhibitor

